Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Structural basis of type II topoisomerase inhibition by the anticancer drug etoposide.

Science (New York, N.Y.) - 22 Jul 2011

Wu Chyuan-Chuan, Li Tsai-Kun, Farh Lynn, Lin Li-Ying, Lin Te-Sheng, Yu Yu-Jen, Yen Tien-Jui, Chiang Chia-Wang, Chan Nei-Li

Abstract excerpt

Type II topoisomerases (TOP2s) resolve the topological problems of DNA by transiently cleaving both strands of a DNA duplex to form a cleavage complex through which another DNA segment can be transported. Several widely prescribed anticancer drugs increase the population of TOP2 cleavage complex, which leads to TOP2-mediated chromosome DNA breakage and death of cancer cells. We present the crystal structure of a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Base Pairing
Share to Catalytic Domain

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to DNA Topoisomerases, Type II

Share to Etoposide

Share to Mutant Proteins

Share to Protein Multimerization

Share to Protein Structure, Quaternary

Share to Topoisomerase II Inhibitors

Source

Identifiers

PMID: 21778401
DOI: 10.1126/science.1204117

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Structural basis of type II topoisomerase inhibition by the anticancer drug etoposide.PMID 21778401Read ↗

Etoposide, Topoisomerase II and CancerSemantic proximity Read ↗

Producing irreversible topoisomerase II-mediated DNA breaks by site-specific Pt(II)-methionine coordination chemistrySemantic proximity Read ↗

Etoposide promotes DNA loop trapping and barrier formation by topoisomerase IISemantic proximity Read ↗

Differential Targeting of Human Topoisomerase II Isoforms with Small MoleculesSemantic proximity Read ↗

The Structure of DNA-Bound Human Topoisomerase II Alpha: Conformational Mechanisms for Coordinating Inter-Subunit Interactions with DNA CleavageSemantic proximity Read ↗

Using energy to go downhill—a genoprotective role for ATPase activity in DNA topoisomerase IISemantic proximity Read ↗

DNA Topoisomerase II Mutations in Cancer: Structural Impact and Drug Response in High-grade Serous Ovarian Carcinoma.Semantic proximity Read ↗

Topoisomerase II poisons inhibit vertebrate DNA replication through distinct mechanismsSemantic proximity Read ↗

Using energy to go downhill – a genoprotective role for ATPase activity in DNA topoisomerase IISemantic proximity Read ↗

DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial DrugsSemantic proximity Read ↗

Reversal of DNA damage induced Topoisomerase 2 DNA-protein crosslinks by Tdp2.Semantic proximity Read ↗

Topoisomerase IIα, rather than IIβ, is a promising target in development of anti-cancer drugsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.